Chip shortage curbs ResMed’s growth in face of surging demand - Sydney Morning Herald

The medtech giant was forced to shave $US100 million off its revenue forecasts for capitalising on a competitor’s recall, with the stock falling 5 per cent.

The global semiconductor shortage has curbed ResMeds ability to meet surging customer demand, but chief executive Mick Farrell is looking beyond the current supply chain crunch. Revenues at the slee… [+1936 chars]

full article...